Expression and activity of antioxidants in the brain in progressive supranuclear palsy

被引:36
|
作者
Cantuti-Castelvetri, I
Keller-McGandy, CE
Albers, DS
Beal, MF
Vonsattel, JP
Standaert, DG
Augood, SJ
机构
[1] Massachusetts Gen Hosp, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Charlestown, MA 02129 USA
[3] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA
关键词
progressive supranuclear palsy; parkinsonism; tau; superoxide dismutase; neurodegeneration; oxidative stress;
D O I
10.1016/S0006-8993(02)02244-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent evidence implicates oxidative stress in the pathophysiology of progressive supranuclear palsy (PSP). Thus, we undertook a study of the activity and localization of two essential antioxidant systems (superoxide dismutase [SOD] enzymes and total glutathione) in the human post-mortem PSP and control brain. Marked increases in SOD1 (Cu/ZnSOD) activity and glutathione levels were measured within most PSP brain regions examined, whereas, only the subthalamic nucleus exhibited a significant increase (+68%) in SOD2 (MnSOD) activity. Two additional cases with mild pathological abnormalities were studied. The first (case A) may represent an example of an asymptomatic PSP case, while the second (case B) had mild pathological abnormalities consistent with typical PSP. In case A, only the STN had elevated levels of SOD activity, in the absence of an increase in tissue glutathione content. In case B, SOD activities and tissue glutathione content were elevated in several regions. Immunolocalization of the SOD1 and SOD2 proteins in paraffin-embedded tissue sections revealed a marked increase in the density of SOD immunopositive profiles (particularly glia) in the typical PSP brain, particularly within the white matter. Together, our data argues strongly in favor of the involvement of oxidative stress in the etiology and progression of PSP, and suggests that deficit in SOD or glutathione metabolism are not causative. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:170 / 181
页数:12
相关论文
共 50 条
  • [1] Progressive supranuclear palsy
    Bartosova, T.
    Klempir, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (06) : 584 - 601
  • [2] Progressive Supranuclear Palsy
    Golbe, Lawrence I.
    SEMINARS IN NEUROLOGY, 2014, 34 (02) : 151 - 159
  • [3] Progressive supranuclear palsy
    Tawana, K
    Ramsden, DB
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2001, 54 (06): : 427 - 434
  • [4] Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy
    Zemaitaitis, MO
    Kim, SY
    Halverson, RA
    Troncoso, JC
    Lee, JM
    Muma, NA
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (02) : 173 - 184
  • [5] Dystonia in progressive supranuclear palsy
    Barclay, CL
    Lang, AE
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (04) : 352 - 356
  • [6] Dysphagia in Progressive Supranuclear Palsy
    Heather M. Clark
    Julie A. G. Stierwalt
    Nirubol Tosakulwong
    Hugo Botha
    Farwa Ali
    Jennifer L. Whitwell
    Keith A. Josephs
    Dysphagia, 2020, 35 : 667 - 676
  • [7] Dysphagia in Progressive Supranuclear Palsy
    Clark, Heather M.
    Stierwalt, Julie A. G.
    Tosakulwong, Nirubol
    Botha, Hugo
    Ali, Farwa
    Whitwell, Jennifer L.
    Josephs, Keith A.
    DYSPHAGIA, 2020, 35 (04) : 667 - 676
  • [8] Immunotherapy in progressive supranuclear palsy
    Vaswani, Pavan A.
    Olsen, Abby L.
    CURRENT OPINION IN NEUROLOGY, 2020, 33 (04) : 527 - 533
  • [9] Interventions in progressive supranuclear palsy
    Koros, Christos
    Stamelou, Maria
    PARKINSONISM & RELATED DISORDERS, 2016, 22 : S93 - S95
  • [10] Tau and saitohin gene expression pattern in progressive supranuclear palsy
    Ezquerra, Mario
    Gaig, Charles
    Ascaso, Carlos
    Munoz, Esteban
    Tolosa, Eduardo
    BRAIN RESEARCH, 2007, 1145 : 168 - 176